Scientific Advisory Board
Ueli Aebi, PhD
Prof. Dr. phil., Ph.D. in Biophysics in 1977 from the University of Basel. Currently, he is emeritus Professor and former Director of the M.E. Müller Institute for Structural Biology at the Biozentrum. In 1981 he co-founded Protek, Inc. (prostheses). Since 1996 he has been chairing the board of Gehring Cut (surgical instruments). In 2003 he co-founded Therapeomic, Inc. (tissue repair). In 2004 he was elected president of the Basel Tumor Bank Foundation. He is also a co-founder of the company Alpha-O Peptides AG, Riehen (2004). He is an expert in the biophysical analysis of SAPNs and has an excellent track-record in structural analysis of viruses and viral proteins. Many decades ago he came up with the idea of repetitive antigen display to induce a strong humoral immune response.
Rima McLeod, PhD
Professor Rima McLeod (University of Chicago), MD is internationally recognized for her expertise and extensive research in toxoplasmosis. She specializes in the comprehensive care of congenital toxoplasmosis and other Toxoplasma gondiiinfections. In the laboratory, Dr. McLeod leads investigative studies designed to ultimately develop more effective screening, detection, vaccination and treatment strategies for toxoplasmosis. She is an expert in vaccine design with experience in adjuvant formulations. Her research examines multiple aspects of this disease, including genetic factors, immune response, and vulnerable populations - specifically, pregnant women and newborns. Dr. McLeod's is a member of the committees on Molecular Medicine, Immunology, and Genetics, and a fellow with the Institute for Genomics and Systems Biology at the University of Chicago.
Mazhar Khan, PhD
Professor Mazhar I. Khan, PhD has been working in the Department of Pathobiology, University of Connecticut, Storrs, CT since 1989. His research interests and expertise are in the development of influenza vaccines (human and animal vaccines). He is further involved with molecular diagnostic techniques such as the development and application of DNA based probes. He has been working on molecular epidemiology and on Salmonella enteritidis-specific vaccine. Molecular characterization of S genes of infectious bronchitis virus (IBV) and pathogenesis of IBV serotypes. Development of recombinant DNA-vectored vaccine and in ovo vaccination trial of a recombinant DNA vaccine for IBV.